Literature DB >> 1619454

The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: a review.

M A Sprangers1, N K Aaronson.   

Abstract

The use of proxy raters of patients' quality of life has been suggested as a means of facilitating the factoring of quality-of-life considerations explicitly into the medical decision-making process and of resolving the problem of missing data in longitudinal quality-of-life investigations. This review addresses two questions related to the potential role of such proxy raters in clinical research and practice: (1) to what extent are health care providers and lay individuals involved in the care of patients ("significant others") able to assess accurately the quality of life of patients with chronic disease? and (2) under what conditions, if any, is inclusion of such proxy ratings in quality-of-life investigations warranted? Although the extant literature yields few unequivocal findings, a number of clear trends can be identified: (i) health care providers and significant others tend, in general, to underestimate patients' quality of life; (ii) health care providers and significant others appear to evaluate patients' quality of life with a comparable degree of (in)accuracy; (iii) health care providers tend to underrate the pain intensity of their patients; (iv) proxy ratings appear to be more accurate when the information sought is concrete and observable; and (v) while significant others' ratings tend to be more accurate when they live in close proximity to the patient, they can also be biased by the caregiving function of the rater. There is need for more methodologically sound studies that: (a) incorporate head-to-head comparisons of health care providers and significant others as proxy raters; (b) employ well-validated quality-of-life measures; and (3) employ a longitudinal design in order to examine the effect of changes in patients' health status over time on the ability of proxies to provide valid quality-of-life assessments.

Entities:  

Mesh:

Year:  1992        PMID: 1619454     DOI: 10.1016/0895-4356(92)90052-o

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  156 in total

1.  Quality of life assessment in adults with type 1 Gaucher disease.

Authors:  B J Masek; K B Sims; C M Bove; M S Korson; P Short; D K Norman
Journal:  Qual Life Res       Date:  1999-05       Impact factor: 4.147

2.  Proxy reliability: health-related quality of life (HRQoL) measures for people with disability.

Authors:  E M Andresen; V J Vahle; D Lollar
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

3.  Is there such a thing as a life not worth living?

Authors:  B Farsides; R J Dunlop
Journal:  BMJ       Date:  2001-06-16

4.  Who should measure quality of life?

Authors:  J Addington-Hall; L Kalra
Journal:  BMJ       Date:  2001-06-09

5.  Randomized trials with quality of life endpoints: are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings?

Authors:  R J Stephens; P Hopwood; D J Girling; D Machin
Journal:  Qual Life Res       Date:  1997-04       Impact factor: 4.147

Review 6.  What clinimetric evidence exists for using hip-specific patient-reported outcome measures in pediatric hip impingement?

Authors:  Agnes G d'Entremont; Anthony P Cooper; Ashok Johari; Kishore Mulpuri
Journal:  Clin Orthop Relat Res       Date:  2015-04       Impact factor: 4.176

7.  The SIP68: an abbreviated sickness impact profile for disability outcomes research.

Authors:  Upasana Nanda; Patricia M McLendon; Elena M Andresen; Eric Armbrecht
Journal:  Qual Life Res       Date:  2003-08       Impact factor: 4.147

8.  Neonatal euthanasia is unsupportable: the Groningen protocol should be abandoned.

Authors:  Alexander A Kon
Journal:  Theor Med Bioeth       Date:  2007

9.  Quality of life on admission to the intensive care: can we query the relatives?

Authors:  Jose Hofhuis; Jeannine L A Hautvast; Augustinus J P Schrijvers; Jan Bakker
Journal:  Intensive Care Med       Date:  2003-05-07       Impact factor: 17.440

Review 10.  Outcome measures and needs assessment tools for schizophrenia and related disorders.

Authors:  S M Gilbody; A O House; T A Sheldon
Journal:  Cochrane Database Syst Rev       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.